(Press-News.org) Dr Marques-Vidal said: "Deaths from cardiovascular disease are higher in winter and lower in summer. We decided to conduct a large scale study to see whether cardiovascular risk factors have a seasonal pattern which could explain the seasonality in deaths."
The study used cross-sectional data from 10 population based studies in 7 countries. Information was obtained on cardiovascular risk factors in 107,090 subjects aged 35 to 80 years. The country breakdown was as follows: 21,128 subjects in Belgium, 15,664 in Denmark, 1,626 in France, 18,370 in Italy, 25,532 in Norway, 9,359 in Russia and 15,411 in Switzerland.
Levels of blood pressure, lipids, glucose, body mass index (BMI, kg/m2) and waist circumference were compared according to season. All data were adjusted for age, gender and smoking. Data on blood pressure, lipids and glucose were adjusted for BMI and whether or not the patient was taking medication.
The researchers found that levels of several cardiovascular risk factors (such as blood pressure, waist circumference and total cholesterol) were higher in winter (January to February) and lower in summer (June to August) compared to the annual average.
Systolic blood pressure levels were on average 3.5 mmHg lower in summer than in winter (see figure). Dr Marques-Vidal said: "Although this difference is almost irrelevant for an individual, it is considerable for a whole population because the whole blood pressure distribution is shifted to higher values, increasing cardiovascular risk. Indeed, the impact of season on blood pressure levels might have as great an impact on cardiovascular risk as genetic markers for blood pressure. This is because the joint effect of genetic markers on blood pressure is modest, between 2 and 3 mmHg."
He added: "We are currently conducting a study involving 50 million deaths in 18 countries to discover whether seasonality of risk factors affects the risk of dying from myocardial infarction or stroke."
Waist circumference was on average 1 cm smaller in summer than in winter, while total cholesterol was on average 0.24 mmol/L lower in summer than in winter. Dr Marques-Vidal said: "We observed a seasonal variation in waist circumference but BMI did not change throughout the year. We have no clear explanation for this finding. Total cholesterol may increase during the winter because of changes in eating habits. There was no seasonal variation in glucose, probably because several cohorts did not collect blood samples in the fasting state. We have begun a study on seasonality of food intake which may help explain these findings."
He added: "Our large scale study shows that some cardiovascular risk factors take holidays over the summer. This may explain why deaths from cardiovascular disease are higher in winter than summer. People need to make an extra effort to exercise and eat healthily in the winter to protect their health."
He concluded: "Our team is currently conducting another study to find out if the seasonal pattern in cardiovascular risk factors reverses in the southern hemisphere, where seasons are inverted relative to the northern hemisphere. Based on preliminary data, it does seem to be the case. The overall study is expected to collect information on almost 200,000 subjects from over 12 countries."
###
Notes to editor
About the European Society of Cardiology
The European Society of Cardiology (ESC) represents more than 80 000 cardiology professionals across Europe and the Mediterranean. Its mission is to reduce the burden of cardiovascular disease in Europe.
About ESC Congress 2013
The ESC Congress is currently the world's premier conference on the science, management and prevention of cardiovascular disease. The spotlight of this year's event is "The Heart Interacting with Systemic Organs". ESC Congress 2013 takes place from 31 August to 4 September at the RAI centre in Amsterdam, Netherlands. More information is available from the ESC Press Office at press@escardio.org
Cardiovascular risk factors highest in winter and lowest in summer
2013-09-01
ELSE PRESS RELEASES FROM THIS DATE:
Out-of-hospital cardiac arrest survival just 7 percent
2013-09-01
Amsterdam, The Netherlands – Sunday 1 September 2013: Survival for out-of-hospital cardiac arrest is just 7%, according to research presented at ESC Congress 2013 by Professor Xavier Jouven and Dr Wulfran Bougouin from France.
Professor Jouven said: "Sudden cardiac death (SCD) is an important public health problem, accounting for more than 400,000 deaths every year. The main cause is ventricular tachyarrhythmias which are often triggered by acute ischaemic events that can occur in persons with or without known heart disease. The survival rate from cardiac arrest has remained ...
Quitting smoking drops heart attack risk to levels of never smokers
2013-09-01
Dr Min said: "Smoking is an established risk factor for cardiovascular disease. Studies have identified that quitting smoking can reduce heart attacks and death but have not examined the relationship of this salutary effect on the presence and severity of coronary artery disease (CAD). Our study aimed to find out what impact stopping smoking had on the risk of cardiovascular events, death and the severity of CAD."
The prospective CONFIRM (Coronary CT Evaluation for Clinical Outcomes: An International Multicenter Study) registry of 13,372 patients from 9 countries in Europe, ...
Family history doubles aortic stenosis risk
2013-09-01
Aortic stenosis is the most common heart valve disease in the elderly. It is associated with congenital bicuspid aortic valve and previous rheumatic heart disease, but is also often caused by calcification of a normal valve. Calcification of a normal valve may be associated with atherosclerotic changes in the portion of the aorta closest to the valve.
Dr Ranthe said: "Genetic factors may play a role in the development of aortic stenosis. A single nucleotide polymorphism in the lipoprotein(a) locus has been associated with aortic valve calcification and aortic stenosis.1 ...
Pre-treatment with prasugrel -- more risk, no benefit: ACCOAST
2013-09-01
AMSTERDAM, The Netherlands – In patients with non-ST-elevation acute coronary syndrome (NSTE- ACS), pre-treatment with the P2Y12 antagonist prasugrel prior to catheterization, significantly increases the risk of life-threatening bleeding without reducing the risk of major ischemic events, according to the results of the ACCOAST (A Comparison of Prasugrel at PCI or Time of Diagnosis of Non-ST Elevation Myocardial Infarction) trial.
The findings point to a "paradigm shift" away from pre-treatment in such patients which will not only be "hard to believe and destabilizing ...
Preventive PCI results in better outcomes than culprit artery PCI alone in ST elevation MI
2013-09-01
AMSTERDAM, The Netherlands – Heart attack patients with ST elevation who undergo a preventive procedure to unblock additional coronary arteries have significantly better outcomes than those whose treatment is confined to the culprit blockage only, according to the results of the Preventive Angioplasty in Myocardial Infarction (PRAMI) Trial.
The findings, presented today at the ESC and published simultaneously in the New England Journal of Medicine, provide information that will help guide clinical practice and resolve uncertainty over how to approach percutaneous coronary ...
A shorter interruption of anti-thrombotics does not influence peri-operative complications
2013-09-01
AMSTERDAM, The Netherlands – A shortened pre-surgical interruption of anti-thrombotic therapy, compared to the more traditional one-week interruption, has no influence on perioperative complications in cardiac patients, according to the results of the PRAGUE 14 trial.
"Thus, there is no evidence to support changing the traditional approach of interrupting antithrombotic therapy one week before surgery," said lead investigator Petr Widimsky, MD., DrSc., from the Cardiocenter of Charles University, in Prague, Czech Republic.
The results shed light on a persistent dilemma ...
Study finds mechanical chest compressions are equally as effective as manual CPR
2013-09-01
"The study was designed to show a better 4-hour survival in the group treated with mechanical chest compressions, and this was not achieved," said lead investigator Sten Rubertsson, MD, PhD, professor and specialist consultant at Uppsala University and Uppsala University Hospital.
"But we now have the scientific support to allow us to use mechanical chest compressions and defibrillate during ongoing compressions," he said, adding that this could potentially increase the efficiency and safety of emergency personnel as they deliver care during transportation of patients. ...
Magnetic resonance imaging before ablation for atrial fibrosis helps predict success of treatment
2013-09-01
AMSTERDAM, The Netherlands – In patients with atrial fibrillation, delayed enhancement magnetic resonance imaging (DE-MRI) performed before ablative treatment can stage the degree of damaged heart tissue (atrial fibrosis) and help predict whether treatment will be successful or not, according to results of Delayed Enhancement - MRI determinant of successful Catheter Ablation of Atrial Fibrillation (DECAAF) trial.
"The DECAAF results show that stage of atrial fibrosis prior to ablation is a new, powerful, independent predictor of outcome," said lead investigator Nasir ...
Hokusai-VTE study suggests certain sub-groups of venous thromboembolism patients may need review
2013-09-01
AMSTERDAM, The Netherlands – In the treatment of venous thromboembolism (VTE), the oral anticoagulant edoxaban resulted in equal efficacy and better safety compared to standard warfarin when either drug was used with initial low molecular weight heparin (LMWH), according to the results of the Hokusai-VTE trial.
In the landscape of new trials with oral anticoagulants, the Hokusai-VTE findings offer fresh insight into a previously under-represented subgroup of patients with pulmonary embolism (PE), suggesting that treatment for this group might need to be different than ...
TASTE trial challenge current practice of blood clot aspiration after heart attack
2013-09-01
AMSTERDAM, The Netherlands -- Aspiration of the blood clot or "thrombus" that causes a heart attack before re-opening a patient's artery with a balloon catheter does not improve survival compared to performing balloon dilation and stenting alone according to the results of the Thrombus Aspiration in ST- Elevation myocardial infarction in Scandinavia (TASTE) trial.
"We believe that TASTE questions the usefulness of thrombus aspiration as a routine adjunct and the recommendation for its general use in international guidelines should probably be down-graded," said lead author ...